Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1).
Acomplia is used in the treatment of obesity and related conditions.
This is from https://www.drugs.com/acomplia.html
"... How does Acomplia work?
Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1.
Acomplia switches off the same brain circuits that make people hungry when they smoke cannabis.
CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism."
Acomplia is used complementary to diet and exercise to treat obese or overweight patients.
See these links for information on healthy and low calorie diets.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 17 Jan 2011 • 1 answer
Posted 2 Nov 2012 • 5 answers
Posted 9 Mar 2015 • 1 answer
Posted 24 Aug 2015 • 0 answers
Posted 8 Sep 2015 • 1 answer